Capital Impact Advisors, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Capital Impact Advisors, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$705.89 - $766.39 $12,000 - $13,028	-17 Reduced 3.8%	430 $310,000
Q3 2022 Nov 21, 2022	SELL	$573.97 - $724.32 $33,290 - $42,010	-58 Reduced 11.49%	447 $308,000
Q2 2022 Aug 15, 2022	SELL	$548.35 - $738.84 $409,069 - $551,174	-746 Reduced 59.63%	505 $299,000
Q1 2022 May 16, 2022	SELL	$595.12 - $698.43 $417,179 - $489,599	-701 Reduced 35.91%	1,251 $874,000
Q4 2021 Feb 14, 2022	SELL	$543.48 - $670.97 $2.51 Million - $3.1 Million	-4,615 Reduced 70.28%	1,952 $1.23 Million
Q3 2021 Nov 15, 2021	BUY	$574.03 - $680.96 $1.92 Million - $2.28 Million	3,344 Added 103.75%	6,567 $3.97 Million
Q2 2021 Aug 17, 2021	BUY	$472.8 - $558.54 $483,201 - $570,827	1,022 Added 46.43%	3,223 $1.8 Million
Q1 2021 May 18, 2021	SELL	$446.73 - $548.2 $855,041 - $1.05 Million	-1,914 Reduced 46.51%	2,201 $1.04 Million
Q3 2020 Nov 13, 2020	SELL	$544.75 - $658.21 $817,125 - $987,315	-1,500 Reduced 26.71%	4,115 $2.3 Million
Q2 2020 Aug 17, 2020	SELL	$493.32 - $643.92 $719,753 - $939,479	-1,459 Reduced 20.62%	5,615 $3.5 Million
Q3 2019 Nov 14, 2019	SELL	$273.46 - $318.39 $138,917 - $161,742	-508 Reduced 6.7%	7,074 $1.93 Million
Q1 2018 Apr 11, 2018	BUY	$315.82 - $393.78 $989,148 - $1.23 Million	3,132 Added 70.38%	7,582 $2.61 Million
Q3 2017 Jan 16, 2018	BUY	$431.38 - $504.0 $1.92 Million - $2.24 Million	4,450	4,450 $1.99 Million

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Capital Impact Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Capital Impact Advisors, LLC with notifications on news.